PNC Financial Services Group’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
MAM
WC
FCM
LG
MCM
AI
IC
PNC Financial Services Group's STIM Position: Q2 2026 in Review
PNC Financial Services Group reduced its Neuronetics (STIM) stake by 48% in Q2 2026, selling an estimated $164 and leaving 124 shares worth $161. The position accounts for ﹤0.01% of the portfolio, ranked #5118.
PNC Financial Services Group first reported a position in STIM in Q2 2020 and has held it in 13 quarters since. The position peaked at $16K in Q2 2021. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.
- PNC Financial Services Group held 124 shares of Neuronetics worth $161 as of Q2 2026.
- PNC Financial Services Group sold 113 Neuronetics shares in Q2 2026, an estimated $164.
- Neuronetics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5118 holding.
- PNC Financial Services Group first reported a position in Neuronetics in Q2 2020 and has held it in 13 quarters since.
- PNC Financial Services Group's Neuronetics position peaked at $16K in Q2 2021.
- 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.